课题基金 / 基金详情

Development and use of novel technologies to improve drugs targeting G protein-coupled receptor complexes involved in disease

Development and use of novel technologies to improve drugs targeting G protein-coupled receptor complexes involved in disease
开发和使用新技术来改进针对疾病相关 G 蛋白偶联受体复合物的药物
批准号:
FT100100271
负责人:
Prof Kevin Pfleger
金额:
$49.83万
依托单位国家:
澳大利亚
项目类别:
ARC Future Fellowships
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2014-12-31

项目摘要

项目成果

Prof Kevin Pfleger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this project is to develop and use new and innovative technologies to improve many of the drugs taken for a wide range of medical conditions. The expected outcomes are the discovery of better drugs and a greater understanding of the drugs currently on the market, particularly enabling improved management of side-effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of technologies to monitor multimolecular complexes
  • 批准号:
    LP160100857
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $34.69万
  • 财政年份:
    2016
  • 负责人:
    Prof Kevin Pfleger
  • 依托单位:
Development of class-leading bioluminescence resonance energy transfer technologies for real-time monitoring of molecular interactions
  • 批准号:
    LP130100037
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $13.43万
  • 财政年份:
    2013
  • 负责人:
    Prof Kevin Pfleger
  • 依托单位:
Investigating the functional interaction between vasopressin and angiotensin receptors
  • 批准号:
    DP120101297
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $19.37万
  • 财政年份:
    2012
  • 负责人:
    Prof Kevin Pfleger
  • 依托单位:
国内基金
海外基金
降低慢病毒载体转录“通读率”的研究
  • 批准号:
    81271690
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    张敬之
  • 依托单位: